Hildred Capital Partners

Hildred Capital Partners

Hildred Capital Partners was founded in 2013 by David Solomon and Andrew Goldman. The New York-based private equity firm concentrates exclusively on middle-market healthcare companies in North America. Both co-founders brought operational and financial backgrounds to the firm, having developed expertise in healthcare services long before they began acquiring platforms. The firm executes buyout and growth-equity investments across healthcare services and digital health. Hildred targets companies with proven business models that can benefit from operational upgrades, strategic repositioning, or roll-up strategies. The team works across subsectors including behavioral health, dental services, home-based care, and technology-enabled healthcare providers. The geographic focus is primarily the United States, where fragmented provider markets present consolidation opportunities. Hildred closed its second fund in 2019 at approximately $475 million, up from a roughly $175 million debut vehicle raised in 2015, signaling growing limited partner conviction in its healthcare specialization. The firm typically writes equity checks for control positions and has built a concentrated portfolio of platform investments. While Hildred has not publicly disclosed detailed portfolio holdings, regulatory filings and industry reports indicate active platform-building in outsourced healthcare services. Hildred operates with a lean, sector-dedicated investment team — a structure that concentrates decision-making among partners and limits the sprawl seen at multi-asset managers. The firm's focus on regulated, reimbursement-dependent services means every investment sits at the intersection of operations and healthcare policy, a combination that requires specialized diligence most generalist private equity firms do not maintain in-house. That narrow aperture is the architecture's central bet.